Refractory, or pharmacoresistant epilepsy affects one in three dogs with epilepsy, and defines them as having frequent and severe seizures, despite appropriate drug therapy. Specialist vet Mark Lowrie joins the Vet Times Podcast to explain some of the challenges for diagnosis, treatment and ongoing management of the condition Dr Lowrie has written an article on this topic for Vet Times (Volume 54, Issue 18, Pages 6-12), called “Canine refractory epilepsy – management considerations”, which is available at https://www.vettimes.co.uk/article/canine-refractory-epilepsy-management-considerations/ ••• 𝗠𝗔𝗥𝗞 𝗟𝗢𝗪𝗥𝗜𝗘, 𝗠𝗔, 𝗩𝗲𝘁𝗠𝗕, 𝗠𝗩𝗠, 𝗗𝗶𝗽𝗘𝗖𝗩𝗡, 𝗠𝗥𝗖𝗩𝗦 An RCVS specialist in veterinary neurology, Mark qualified from the University of Cambridge and then worked in first opinion small animal practice. Following an internship at the RVC, he moved to the University of Glasgow to complete a residency in veterinary neurology. He has a master’s degree in steroid responsive meningitis-arteritis in dogs and has a particular interest in involuntary muscle contractions, reflex epilepsy, inflammatory central nervous system disease and feline neurology. He is a director at Movement Referrals, a veterinary consultant to the International Society of Feline Medicine and Petplan’s “Vet of the Year” 2022.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Trump $82 Million Bond Spree, Brazil Tariffs 'Too High,' More
16 Nov 2025
Bloomberg News Now
Ex-Fed Gov Resigned After Rules Violations, Trump Buys $82 Mil of Bonds, More
16 Nov 2025
Bloomberg News Now
THIS TRUMP INTERVIEW WAS INSANE!
16 Nov 2025
HasanAbi
Epstein Emails and Trump's Alleged Involvement
15 Nov 2025
Conspiracy Theories Exploring The Unseen
New Epstein Emails Directly Implicate Trump - H3 Show #211
15 Nov 2025
H3 Podcast
Trump Humiliates Himself on FOX as They Call Him Out
15 Nov 2025
IHIP News